Soars Biotech
Sort by
10 items
-
MarketWatch - Business
Wave Life Sciences’ stock soars 51% after biotech posts positive data from Duchenne muscular-dystrophy trial
Biotech reported positive interim data from a mid-stage trial of a treatment for the rare muscle disorder Duchenne muscular dystrophy.8 hours ago -
MarketWatch - Business
Chinese stocks soar on stimulus plan. Can the rally continue?
China’s stock market surged the most in more than two years and industrial commodity prices bounced after Beijing on Tuesday unleashed a swathe of stimulus measures.13 hours ago -
Inc. - Business
AI's Failure in Biotech? A Reality Check on What Really Matters
By focusing on data quality, domain-specific knowledge, and the synergy between humans and machine learning, AI and biotech are on the way to transformative breakthroughs.2 days ago -
MarketWatch - Business
Why the S&P 500 could soar above 6,000 by year-end
A 1990s-like market boom is more likely after Fed rate cut, investment strategist Ed Yardeni says.3 days ago -
CNBC - Business
Japan's Nikkei leads gains in Asia Pacific after Wall Street soars; BOJ and PBOC hold rates
Traders in Asia also look toward August consumer prices index from Japan and Hong Kong, and central bank decisions from Bank of Japan and People's Bank of China.4 days ago - Japan